Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring.

Saved in:
Bibliographic Details
Title: Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring.
Authors: van Bilsen K; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Vergouwen DPC; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van Velthoven MEJ; Centrum Medical Retinal and Uveitis, The Rotterdam Eye Hospital, Rotterdam, The Netherlands., Missotten TOAR; Centrum Medical Retinal and Uveitis, The Rotterdam Eye Hospital, Rotterdam, The Netherlands., Rombach SM; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van Zelm MC; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology and Pathology, Central Clinical School, Monash University and Alfred Hospital, Melbourne, Australia., Berkowska MA; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., van Hagen PM; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Kuijpers RWAM; Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Ophthalmology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.; Department of Ophthalmology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., van Laar JAM; Department of Internal Medicine, Section Clinical Immunology Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Sep; Vol. 32 (7), pp. 1268-1273. Date of Electronic Publication: 2023 Jul 12.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first